According to data from a study by Bhojwani et al., the expression of the genes HOXA7, S100A10, and S100A11 was significantly higher in B-ALL patients who relapsed within 24 months than in those who did not (4). This evidence concerns the gene HOXA7 and acute lymphoblastic leukemia.